McGrath Pam
Centre for Community Science in Griffith Health Institute at Griffith University in Meadowbrook, Queensland, Australia.
Oncol Nurs Forum. 2015 May;42(3):E250-6. doi: 10.1188/15.ONF.E250-E256.
PURPOSE/OBJECTIVES: To present the findings from recent research on the experience of relocation for specialist treatment for patients in the hematology/oncology population.
Descriptive, qualitative study based on exploratory, in-depth interviews that were recorded, transcribed, coded, and thematically analyzed.
Leukaemia Foundation of Queensland, Australia.
A purposive sample of 45 individuals with hematologic cancer who had to relocate for specialist treatment.
A descriptive, qualitative methodology actioned through open-ended, in-depth interviews with 45 participants who relocated for specialist treatment.
The findings indicate that relocation happens at a time when patients are particularly emotionally vulnerable from the shock of their diagnosis or relapse and the confrontation with a potentially life-threatening condition. During this time, when the need for the comfort and support of home and family is heightened, patients have to separate from their family and travel to metropolitan specialist centers. For patients from regional, rural, and remote locations, which are lengthy distances from metropolitan hospitals, the choice to return home during treatment is not a realistic option. Distance also can be a barrier that prevents family from visiting the hospital to provide support.
Individuals who have to relocate require psychosocial support. Because of the stresses associated with relocation for specialist care, many patients from regional, rural, and remote areas would prefer to be treated locally.
Understanding and responding to family issues associated with relocation for specialist treatment is an important aspect of oncology nursing care for patients who have to relocate from regional, rural, and remote areas. Because centralization of specialist hematology treatment is a worldwide trend, the findings have relevance to an international nursing audience.
目的/目标：介绍近期关于血液学/肿瘤学患者转至专科治疗地点的经历的研究结果。
基于探索性深入访谈的描述性定性研究，访谈进行了录音、转录、编码和主题分析。
澳大利亚昆士兰白血病基金会。
45名因专科治疗而不得不转至其他地点的血液系统癌症患者的目的抽样。
通过对45名因专科治疗而转至其他地点的参与者进行开放式深入访谈，采用描述性定性方法。
结果表明，转至其他地点发生在患者因诊断或复发的冲击以及面临潜在危及生命的状况而在情绪上特别脆弱的时候。在此期间，当对家庭舒适和支持的需求增加时，患者不得不与家人分离并前往大城市的专科中心。对于来自距离大城市医院较远的地区、农村和偏远地区的患者来说，在治疗期间回家并非现实选择。距离也可能成为阻碍家人前往医院提供支持的障碍。
不得不转至其他地点的患者需要心理社会支持。由于因专科护理而转至其他地点带来的压力，许多来自地区、农村和偏远地区的患者更希望在当地接受治疗。
理解并应对与转至专科治疗地点相关的家庭问题，是对不得不从地区、农村和偏远地区转至其他地点的肿瘤患者进行护理的重要方面。由于专科血液学治疗集中化是全球趋势，这些研究结果对国际护理领域具有参考价值。
